Denali Therapeutics Inc. (DNLI) Revenue History
Denali Therapeutics Inc. (DNLI) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2018-12-31 | $129.16M |
| 2019-12-31 | $26.32M |
| 2020-12-31 | $335.56M |
| 2021-12-31 | $48.66M |
| 2022-12-31 | $105.06M |
| 2023-12-31 | $330.53M |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How DNLI compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc. | $49.80M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
| VRCA | Verrica Pharmaceuticals Inc. | $35.58M |
| EYPT | EyePoint Pharmaceuticals Inc. | $31.37M |
| ALEC | Alector Inc. | $21.05M |
These are five companies in the same sector as DNLI with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Denali Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("DNLI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | DNLI | $19.72 | -2.04% | 2.96M |
| 3 | ||||
| 4 | ||||
| 5 |